Bloom Science
Paolo Baroldi is currently the Chief Medical Officer at Bloom Science, Inc. with a focus on COVID-19, oncology, and ophthalmology. With a background in various pharmaceutical companies such as Evergreen Pharmaceuticals, Vanda Pharmaceuticals, and Supernus Pharmaceuticals, Paolo has extensive experience in clinical development and regulatory affairs. Paolo also taught Bioscience Regulatory Affairs at Johns Hopkins University and held positions in global clinical pharmacology at Novartis. Paolo's academic background includes a Medical Degree and PhD in Clinical Pharmacology from Università degli Studi di Milano.
This person is not in any offices
Bloom Science
Bloom Science, Inc. is a platform biotechnology company discovering and developing revolutionary new drugs targeting the gut-brain axis for the treatment and modification of diseases with high unmet need in neurology, immunology and oncology.